nodes	percent_of_prediction	percent_of_DWPC	metapath
Framycetin—Malabsorption—Risedronate—osteoporosis	0.0872	0.136	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.0442	0.123	CbGpPWpGaD
Framycetin—Impaired healing—Alendronate—osteoporosis	0.0364	0.057	CcSEcCtD
Framycetin—Eye infection—Estradiol—osteoporosis	0.0273	0.0427	CcSEcCtD
Framycetin—Nephropathy toxic—Ibandronate—osteoporosis	0.0267	0.0418	CcSEcCtD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—DKK1—osteoporosis	0.0238	0.066	CbGpPWpGaD
Framycetin—Nephropathy toxic—Pamidronate—osteoporosis	0.0209	0.0327	CcSEcCtD
Framycetin—Nephropathy toxic—Zoledronate—osteoporosis	0.0191	0.0299	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.0167	0.0463	CbGpPWpGaD
Framycetin—Swelling—Ibandronate—osteoporosis	0.0126	0.0197	CcSEcCtD
Framycetin—Swelling—Pamidronate—osteoporosis	0.00989	0.0155	CcSEcCtD
Framycetin—Viral infection—Estradiol—osteoporosis	0.00937	0.0147	CcSEcCtD
Framycetin—CXCR4—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.00933	0.0259	CbGpPWpGaD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—IGF1—osteoporosis	0.00919	0.0255	CbGpPWpGaD
Framycetin—Swelling—Zoledronate—osteoporosis	0.00904	0.0141	CcSEcCtD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—osteoporosis	0.00888	0.0246	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—PTH1R—osteoporosis	0.00876	0.0243	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CALCR—osteoporosis	0.00876	0.0243	CbGpPWpGaD
Framycetin—Swelling—Conjugated Estrogens—osteoporosis	0.0087	0.0136	CcSEcCtD
Framycetin—Erythema—Etidronic acid—osteoporosis	0.00809	0.0126	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—CNR2—osteoporosis	0.00741	0.0206	CbGpPWpGaD
Framycetin—Hypersensitivity—Calcium Acetate—osteoporosis	0.00741	0.0116	CcSEcCtD
Framycetin—Pruritus—Calcium Acetate—osteoporosis	0.00711	0.0111	CcSEcCtD
Framycetin—Erythema—Estropipate—osteoporosis	0.007	0.0109	CcSEcCtD
Framycetin—Swelling—Estradiol—osteoporosis	0.00696	0.0109	CcSEcCtD
Framycetin—Erythema—Alendronate—osteoporosis	0.00689	0.0108	CcSEcCtD
Framycetin—Diarrhoea—Calcium Acetate—osteoporosis	0.00688	0.0108	CcSEcCtD
Framycetin—CXCR4—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00687	0.0191	CbGpPWpGaD
Framycetin—Erythema—Ibandronate—osteoporosis	0.00671	0.0105	CcSEcCtD
Framycetin—Erythema—Calcitriol—osteoporosis	0.00657	0.0103	CcSEcCtD
Framycetin—Infection—Etidronic acid—osteoporosis	0.00656	0.0103	CcSEcCtD
Framycetin—Vomiting—Calcium Acetate—osteoporosis	0.00639	0.01	CcSEcCtD
Framycetin—CXCR4—HIV Infection—PSMA5—osteoporosis	0.00637	0.0177	CbGpPWpGaD
Framycetin—CXCR4—HIV Infection—PSMA2—osteoporosis	0.00637	0.0177	CbGpPWpGaD
Framycetin—Nausea—Calcium Acetate—osteoporosis	0.00597	0.00934	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00589	0.0163	CbGpPWpGaD
Framycetin—Anaphylactic shock—Estropipate—osteoporosis	0.00571	0.00893	CcSEcCtD
Framycetin—Infection—Estropipate—osteoporosis	0.00567	0.00887	CcSEcCtD
Framycetin—Infection—Alendronate—osteoporosis	0.00559	0.00874	CcSEcCtD
Framycetin—CXCR4—Cardiac Progenitor Differentiation—TGFB1—osteoporosis	0.00551	0.0153	CbGpPWpGaD
Framycetin—Infection—Raloxifene—osteoporosis	0.00549	0.00859	CcSEcCtD
Framycetin—Anaphylactic shock—Ibandronate—osteoporosis	0.00548	0.00856	CcSEcCtD
Framycetin—Infection—Ibandronate—osteoporosis	0.00544	0.00851	CcSEcCtD
Framycetin—Anaphylactic shock—Calcitriol—osteoporosis	0.00536	0.00838	CcSEcCtD
Framycetin—Nausea—Ergocalciferol—osteoporosis	0.00528	0.00825	CcSEcCtD
Framycetin—Erythema—Pamidronate—osteoporosis	0.00526	0.00822	CcSEcCtD
Framycetin—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—osteoporosis	0.0052	0.0144	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PTH1R—osteoporosis	0.00495	0.0137	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CALCR—osteoporosis	0.00495	0.0137	CbGpPWpGaD
Framycetin—Hypersensitivity—Etidronic acid—osteoporosis	0.00486	0.0076	CcSEcCtD
Framycetin—Erythema—Zoledronate—osteoporosis	0.0048	0.00751	CcSEcCtD
Framycetin—Pruritus—Etidronic acid—osteoporosis	0.00467	0.0073	CcSEcCtD
Framycetin—Erythema—Conjugated Estrogens—osteoporosis	0.00462	0.00723	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—PTH—osteoporosis	0.0046	0.0128	CbGpPWpGaD
Framycetin—Infection—Ethinyl Estradiol—osteoporosis	0.0046	0.00719	CcSEcCtD
Framycetin—Diarrhoea—Etidronic acid—osteoporosis	0.00452	0.00706	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—CALCR—osteoporosis	0.0045	0.0125	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PTH1R—osteoporosis	0.0045	0.0125	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CNR2—osteoporosis	0.00449	0.0124	CbGpPWpGaD
Framycetin—Infection—Risedronate—osteoporosis	0.00448	0.00701	CcSEcCtD
Framycetin—Anaphylactic shock—Pamidronate—osteoporosis	0.00429	0.00671	CcSEcCtD
Framycetin—Infection—Pamidronate—osteoporosis	0.00426	0.00666	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—WNT1—osteoporosis	0.00422	0.0117	CbGpPWpGaD
Framycetin—Hypersensitivity—Estropipate—osteoporosis	0.00421	0.00658	CcSEcCtD
Framycetin—Vomiting—Etidronic acid—osteoporosis	0.0042	0.00656	CcSEcCtD
Framycetin—CXCR4—Disease—PKM—osteoporosis	0.00419	0.0116	CbGpPWpGaD
Framycetin—CXCR4—Disease—SOST—osteoporosis	0.00419	0.0116	CbGpPWpGaD
Framycetin—Hypersensitivity—Alendronate—osteoporosis	0.00414	0.00648	CcSEcCtD
Framycetin—Pruritus—Estropipate—osteoporosis	0.00404	0.00632	CcSEcCtD
Framycetin—Hypersensitivity—Ibandronate—osteoporosis	0.00403	0.00631	CcSEcCtD
Framycetin—Pruritus—Alendronate—osteoporosis	0.00398	0.00622	CcSEcCtD
Framycetin—CXCR4—Disease—PGLS—osteoporosis	0.00398	0.011	CbGpPWpGaD
Framycetin—CXCR4—Disease—ANTXR2—osteoporosis	0.00398	0.011	CbGpPWpGaD
Framycetin—Hypersensitivity—Calcitriol—osteoporosis	0.00395	0.00617	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—ADCY5—osteoporosis	0.00394	0.0109	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—MGLL—osteoporosis	0.00393	0.0109	CbGpPWpGaD
Framycetin—Nausea—Etidronic acid—osteoporosis	0.00392	0.00613	CcSEcCtD
Framycetin—Anaphylactic shock—Zoledronate—osteoporosis	0.00392	0.00613	CcSEcCtD
Framycetin—Diarrhoea—Estropipate—osteoporosis	0.00391	0.00611	CcSEcCtD
Framycetin—Infection—Zoledronate—osteoporosis	0.00389	0.00609	CcSEcCtD
Framycetin—Pruritus—Ibandronate—osteoporosis	0.00387	0.00606	CcSEcCtD
Framycetin—Diarrhoea—Alendronate—osteoporosis	0.00385	0.00602	CcSEcCtD
Framycetin—CXCR4—GPCR ligand binding—PTHLH—osteoporosis	0.00381	0.0106	CbGpPWpGaD
Framycetin—Pruritus—Calcitriol—osteoporosis	0.00379	0.00593	CcSEcCtD
Framycetin—Diarrhoea—Raloxifene—osteoporosis	0.00378	0.00592	CcSEcCtD
Framycetin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00377	0.0059	CcSEcCtD
Framycetin—Infection—Conjugated Estrogens—osteoporosis	0.00375	0.00586	CcSEcCtD
Framycetin—Diarrhoea—Ibandronate—osteoporosis	0.00375	0.00586	CcSEcCtD
Framycetin—Erythema—Estradiol—osteoporosis	0.0037	0.00579	CcSEcCtD
Framycetin—Diarrhoea—Calcitriol—osteoporosis	0.00367	0.00573	CcSEcCtD
Framycetin—Vomiting—Estropipate—osteoporosis	0.00363	0.00568	CcSEcCtD
Framycetin—Vomiting—Alendronate—osteoporosis	0.00358	0.00559	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—MGLL—osteoporosis	0.00357	0.00991	CbGpPWpGaD
Framycetin—Vomiting—Raloxifene—osteoporosis	0.00352	0.0055	CcSEcCtD
Framycetin—Vomiting—Ibandronate—osteoporosis	0.00348	0.00544	CcSEcCtD
Framycetin—CXCR4—Peptide ligand-binding receptors—POMC—osteoporosis	0.00344	0.00954	CbGpPWpGaD
Framycetin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00341	0.00533	CcSEcCtD
Framycetin—Vomiting—Calcitriol—osteoporosis	0.00341	0.00533	CcSEcCtD
Framycetin—Nausea—Estropipate—osteoporosis	0.00339	0.0053	CcSEcCtD
Framycetin—CXCR4—Disease—GSN—osteoporosis	0.00338	0.00938	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—CALCA—osteoporosis	0.00336	0.00932	CbGpPWpGaD
Framycetin—Nausea—Alendronate—osteoporosis	0.00334	0.00522	CcSEcCtD
Framycetin—Hypersensitivity—Risedronate—osteoporosis	0.00332	0.0052	CcSEcCtD
Framycetin—Nausea—Raloxifene—osteoporosis	0.00329	0.00514	CcSEcCtD
Framycetin—Pruritus—Ethinyl Estradiol—osteoporosis	0.00327	0.00512	CcSEcCtD
Framycetin—Nausea—Ibandronate—osteoporosis	0.00325	0.00509	CcSEcCtD
Framycetin—Pruritus—Risedronate—osteoporosis	0.00319	0.00499	CcSEcCtD
Framycetin—Nausea—Calcitriol—osteoporosis	0.00318	0.00498	CcSEcCtD
Framycetin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00317	0.00495	CcSEcCtD
Framycetin—Hypersensitivity—Pamidronate—osteoporosis	0.00316	0.00494	CcSEcCtD
Framycetin—Diarrhoea—Risedronate—osteoporosis	0.00309	0.00483	CcSEcCtD
Framycetin—Pruritus—Pamidronate—osteoporosis	0.00303	0.00475	CcSEcCtD
Framycetin—Anaphylactic shock—Estradiol—osteoporosis	0.00302	0.00472	CcSEcCtD
Framycetin—Infection—Estradiol—osteoporosis	0.003	0.00469	CcSEcCtD
Framycetin—Vomiting—Ethinyl Estradiol—osteoporosis	0.00294	0.0046	CcSEcCtD
Framycetin—CXCR4—Disease—LRP5—osteoporosis	0.00294	0.00816	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SOST—osteoporosis	0.00294	0.00815	CbGpPWpGaD
Framycetin—Diarrhoea—Pamidronate—osteoporosis	0.00294	0.00459	CcSEcCtD
Framycetin—CXCR4—G alpha (i) signalling events—POMC—osteoporosis	0.0029	0.00805	CbGpPWpGaD
Framycetin—Hypersensitivity—Zoledronate—osteoporosis	0.00289	0.00451	CcSEcCtD
Framycetin—Vomiting—Risedronate—osteoporosis	0.00287	0.00449	CcSEcCtD
Framycetin—CXCR4—Disease—LRP6—osteoporosis	0.00281	0.0078	CbGpPWpGaD
Framycetin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00278	0.00435	CcSEcCtD
Framycetin—Pruritus—Zoledronate—osteoporosis	0.00277	0.00433	CcSEcCtD
Framycetin—Nausea—Ethinyl Estradiol—osteoporosis	0.00275	0.0043	CcSEcCtD
Framycetin—Vomiting—Pamidronate—osteoporosis	0.00273	0.00426	CcSEcCtD
Framycetin—CXCR4—Disease—LTF—osteoporosis	0.0027	0.0075	CbGpPWpGaD
Framycetin—CXCR4—Disease—RPL24—osteoporosis	0.0027	0.0075	CbGpPWpGaD
Framycetin—Diarrhoea—Zoledronate—osteoporosis	0.00268	0.00419	CcSEcCtD
Framycetin—Nausea—Risedronate—osteoporosis	0.00268	0.00419	CcSEcCtD
Framycetin—Pruritus—Conjugated Estrogens—osteoporosis	0.00267	0.00417	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—CALCR—osteoporosis	0.00266	0.00737	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTH1R—osteoporosis	0.00266	0.00737	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PTH—osteoporosis	0.0026	0.00722	CbGpPWpGaD
Framycetin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00258	0.00404	CcSEcCtD
Framycetin—Nausea—Pamidronate—osteoporosis	0.00255	0.00398	CcSEcCtD
Framycetin—CXCR4—GPCR downstream signaling—CNR2—osteoporosis	0.00253	0.00703	CbGpPWpGaD
Framycetin—Vomiting—Zoledronate—osteoporosis	0.00249	0.0039	CcSEcCtD
Framycetin—Vomiting—Conjugated Estrogens—osteoporosis	0.0024	0.00375	CcSEcCtD
Framycetin—CXCR4—Signaling by GPCR—PTH—osteoporosis	0.00236	0.00655	CbGpPWpGaD
Framycetin—CXCR4—Disease—ACP5—osteoporosis	0.00234	0.0065	CbGpPWpGaD
Framycetin—Nausea—Zoledronate—osteoporosis	0.00233	0.00364	CcSEcCtD
Framycetin—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00231	0.0064	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CNR2—osteoporosis	0.0023	0.00639	CbGpPWpGaD
Framycetin—Nausea—Conjugated Estrogens—osteoporosis	0.00224	0.0035	CcSEcCtD
Framycetin—Hypersensitivity—Estradiol—osteoporosis	0.00222	0.00348	CcSEcCtD
Framycetin—CXCR4—Disease—TPI1—osteoporosis	0.00218	0.00604	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—WNT1—osteoporosis	0.00216	0.006	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—PTHLH—osteoporosis	0.00216	0.00598	CbGpPWpGaD
Framycetin—Pruritus—Estradiol—osteoporosis	0.00214	0.00334	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—MGLL—osteoporosis	0.00211	0.00585	CbGpPWpGaD
Framycetin—Diarrhoea—Estradiol—osteoporosis	0.00207	0.00323	CcSEcCtD
Framycetin—CXCR4—Signaling Pathways—LRP5—osteoporosis	0.00206	0.00571	CbGpPWpGaD
Framycetin—CXCR4—Disease—P4HB—osteoporosis	0.00205	0.00568	CbGpPWpGaD
Framycetin—CXCR4—Disease—GAPDH—osteoporosis	0.00201	0.00558	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LRP6—osteoporosis	0.00197	0.00547	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—PTHLH—osteoporosis	0.00196	0.00543	CbGpPWpGaD
Framycetin—Vomiting—Estradiol—osteoporosis	0.00192	0.003	CcSEcCtD
Framycetin—CXCR4—Disease—NFATC1—osteoporosis	0.00191	0.0053	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—CALCA—osteoporosis	0.0019	0.00526	CbGpPWpGaD
Framycetin—CXCR4—Disease—DKK1—osteoporosis	0.0019	0.00526	CbGpPWpGaD
Framycetin—CXCR4—Disease—WNT1—osteoporosis	0.00183	0.00506	CbGpPWpGaD
Framycetin—Nausea—Estradiol—osteoporosis	0.00179	0.0028	CcSEcCtD
Framycetin—CXCR4—Disease—FGA—osteoporosis	0.00178	0.00493	CbGpPWpGaD
Framycetin—CXCR4—GPCR ligand binding—POMC—osteoporosis	0.00176	0.00487	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—CALCA—osteoporosis	0.00172	0.00478	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TLN1—osteoporosis	0.00166	0.00461	CbGpPWpGaD
Framycetin—CXCR4—Disease—ENO1—osteoporosis	0.00158	0.00439	CbGpPWpGaD
Framycetin—CXCR4—Disease—PSMA2—osteoporosis	0.00156	0.00433	CbGpPWpGaD
Framycetin—CXCR4—Disease—PSMA5—osteoporosis	0.00156	0.00433	CbGpPWpGaD
Framycetin—CXCR4—Disease—CALCA—osteoporosis	0.00145	0.00403	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—P4HB—osteoporosis	0.00143	0.00398	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTH—osteoporosis	0.0014	0.00387	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—RAP1A—osteoporosis	0.00137	0.0038	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CNR2—osteoporosis	0.00136	0.00377	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—ADCY5—osteoporosis	0.00135	0.00374	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—NFATC1—osteoporosis	0.00134	0.00371	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—DKK1—osteoporosis	0.00133	0.00368	CbGpPWpGaD
Framycetin—CXCR4—Disease—KL—osteoporosis	0.00132	0.00366	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—WNT1—osteoporosis	0.00128	0.00355	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGA—osteoporosis	0.00124	0.00345	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—ADCY5—osteoporosis	0.00123	0.0034	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PTHLH—osteoporosis	0.00116	0.00321	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—BMP2—osteoporosis	0.00116	0.00321	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—FGB—osteoporosis	0.00113	0.00314	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PSMA5—osteoporosis	0.00109	0.00303	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—PSMA2—osteoporosis	0.00109	0.00303	CbGpPWpGaD
Framycetin—CXCR4—Disease—ADCY5—osteoporosis	0.00103	0.00287	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—CALCA—osteoporosis	0.00102	0.00282	CbGpPWpGaD
Framycetin—CXCR4—GPCR downstream signaling—POMC—osteoporosis	0.000993	0.00275	CbGpPWpGaD
Framycetin—CXCR4—Disease—MTHFR—osteoporosis	0.000951	0.00264	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—KL—osteoporosis	0.000924	0.00256	CbGpPWpGaD
Framycetin—CXCR4—Disease—IRS2—osteoporosis	0.000905	0.00251	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—POMC—osteoporosis	0.000902	0.0025	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6R—osteoporosis	0.000879	0.00244	CbGpPWpGaD
Framycetin—CXCR4—Disease—IRS1—osteoporosis	0.00079	0.00219	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6R—osteoporosis	0.000742	0.00206	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ADCY5—osteoporosis	0.000724	0.00201	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—SPP1—osteoporosis	0.0007	0.00194	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IRS2—osteoporosis	0.000633	0.00176	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—LEP—osteoporosis	0.00062	0.00172	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—ESR1—osteoporosis	0.000592	0.00164	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IRS1—osteoporosis	0.000553	0.00153	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—POMC—osteoporosis	0.000533	0.00148	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6R—osteoporosis	0.00052	0.00144	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IGF1—osteoporosis	0.000512	0.00142	CbGpPWpGaD
Framycetin—CXCR4—Disease—MYC—osteoporosis	0.00044	0.00122	CbGpPWpGaD
Framycetin—CXCR4—Disease—TGFB1—osteoporosis	0.000439	0.00122	CbGpPWpGaD
Framycetin—CXCR4—Signaling by GPCR—IL6—osteoporosis	0.000392	0.00109	CbGpPWpGaD
Framycetin—CXCR4—Disease—IL6—osteoporosis	0.00033	0.000917	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—MYC—osteoporosis	0.000308	0.000854	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—TGFB1—osteoporosis	0.000307	0.000852	CbGpPWpGaD
Framycetin—CXCR4—Signaling Pathways—IL6—osteoporosis	0.000231	0.000642	CbGpPWpGaD
